Details for New Drug Application (NDA): 217569
✉ Email this page to a colleague
NDA 217569 describes VASOPRESSIN IN SODIUM CHLORIDE 0.9%, which is a drug marketed by Baxter Hlthcare Corp and Long Grove Pharms and is included in two NDAs. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the VASOPRESSIN IN SODIUM CHLORIDE 0.9% profile page.
The generic ingredient in VASOPRESSIN IN SODIUM CHLORIDE 0.9% is vasopressin. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the vasopressin profile page.
The generic ingredient in VASOPRESSIN IN SODIUM CHLORIDE 0.9% is vasopressin. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the vasopressin profile page.
Summary for 217569
| Tradename: | VASOPRESSIN IN SODIUM CHLORIDE 0.9% |
| Applicant: | Baxter Hlthcare Corp |
| Ingredient: | vasopressin |
| Patents: | 1 |
Pharmacology for NDA: 217569
| Physiological Effect | Decreased Diuresis Vasoconstriction |
Suppliers and Packaging for NDA: 217569
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| VASOPRESSIN IN SODIUM CHLORIDE 0.9% | vasopressin | SOLUTION;INTRAVENOUS | 217569 | NDA | Baxter Healthcare Corporation | 0338-9640 | 0338-9640-12 | 12 BAG in 1 CARTON (0338-9640-12) / 100 mL in 1 BAG |
| VASOPRESSIN IN SODIUM CHLORIDE 0.9% | vasopressin | SOLUTION;INTRAVENOUS | 217569 | NDA | Baxter Healthcare Corporation | 0338-9647 | 0338-9647-12 | 12 BAG in 1 CARTON (0338-9647-12) / 100 mL in 1 BAG |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 20UNITS/100ML (0.2UNITS/ML) | ||||
| Approval Date: | Sep 29, 2023 | TE: | RLD: | Yes | |||||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Sep 27, 2044 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 40UNITS/100ML (0.4UNITS/ML) | ||||
| Approval Date: | Sep 29, 2023 | TE: | RLD: | Yes | |||||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Sep 27, 2044 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Complete Access Available with Subscription
